2023 annual financial data
Niagen Bioscience 2023 Net margin
Direct answer
Net margin was -5.91%.
Operating income was -5,599,000 USD and net income was -4,938,000 USD.
Operating cash flow was 7,117,000 USD.
Get free Niagen Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 83,570,000 USD
- Operating income
- -5,599,000 USD
- Net income
- -4,938,000 USD
- Operating cash flow
- 7,117,000 USD